Bone Loss Completed Phase 2 Trials for Lasofoxifene (DB06202)
Also known as: Osteopenia / Osteopenia (disorder) / Osteopenia (morphologic abnormality) / Osteopaenia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031952 (Bone Loss) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00674453 | The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation | Basic Science |